In-depth Biological Monitoring to Estimate Effects of Red or Processed Meat on Colorectal Cancer.
1/5 보강
: The intake of red or processed meat remains controversial as a crucial factor for CRC.
- 표본수 (n) 218
APA
Lee JS, Kim E, et al. (2026). In-depth Biological Monitoring to Estimate Effects of Red or Processed Meat on Colorectal Cancer.. Journal of Cancer, 17(2), 395-403. https://doi.org/10.7150/jca.126466
MLA
Lee JS, et al.. "In-depth Biological Monitoring to Estimate Effects of Red or Processed Meat on Colorectal Cancer.." Journal of Cancer, vol. 17, no. 2, 2026, pp. 395-403.
PMID
41584039
Abstract
: The intake of red or processed meat remains controversial as a crucial factor for CRC. Thus, we performed in-depth biological monitoring. We performed a case- control study and analyzed various exposure and response biomarkers including 1-OHP, MeIQx, and PhIP, and malondialdehyde (MDA), and heterocyclic amine (HCA)-DNA adducts in Korean cases and controls (N = 218). They consumed 53.4 ± 74.0 g/day of red meat and 1.1 ± 3.7 g/day of processed meat. The CRC presence was associated with sex, BMI, tobacco smoking, alcohol drinking, cooking method of meat, and vegetable consumption, rather than red or processed meat intake. The levels of MDA were positively associated with those of 1-OHP, MeIQx, or PhIP. The sum of 1-OHP, MeIQx, and PhIP was associated with the levels of HCA-DNA adducts and cooking method of meat. In addition, the above biomarkers for CRC were associated with each other. However, most of these biomarkers were not higher in CRC patients than those in controls. The present in-depth biological monitoring provides that red or processed meat may induce oxidative stress; however, present intake of the meat and the intake-related oxidative stress may not affect CRC prevalence among the Korean population, who consume less meat than Westerners.
같은 제1저자의 인용 많은 논문 (5)
- Redefining the Septal L-Strut to Prevent Collapse.
- Impact of Subtype Variability on Clinical Features in Papillary Thyroid Cancer.
- Four-Year Outcomes for Nivolumab With Chemotherapy and Bevacizumab in Patients With Nonsquamous NSCLC in the TASUKI-52.
- Evolving Molecular Subtypes of Gastric Cancer: From Past Classifications to Present Consensus and Future Directions for Precision Therapy.
- Comparison of Transoral Robotic Thyroidectomy and Transoral Endoscopic Thyroidectomy via Vestibular Approach Using an Endoscopic Retractor: A Single-Center Experience.